STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Biogen (Nasdaq: BIIB), Praxis Precision Medicines ...
GeneDx leverages a vast rare disease database and advanced genomic testing, offering superior insights over traditional panel testing. The company achieved a significant turnaround, becoming cash flow ...
Many historically marginalized populations have faced differential access to COVID-19 resources, such as testing, vaccinations, or therapeutics. To date, national efforts to increase access to ...
More than four years after the COVID-19 pandemic caused the world to come to a standstill, lessons in pandemic response are still being learned. What we know: the global pandemic disproportionately ...
Hossein Borghaei, DO, MS: I’m going to come back to our physicians. Ms. Ferris, I’m going to need your input in the next section also. I want to start talking about all the barriers we’re facing and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback